Inizio Group Limited, headquartered in Great Britain, is a leading player in the healthcare and life sciences industry. Founded in 2021, the company has rapidly established itself as a trusted partner for organisations seeking innovative solutions in clinical development, commercialisation, and market access. With a strong presence across Europe and North America, Inizio Group offers a diverse range of services, including strategic consulting, data analytics, and patient engagement. What sets Inizio Group apart is its commitment to delivering tailored solutions that enhance patient outcomes and drive business success. The company has achieved significant milestones, positioning itself as a go-to resource for pharmaceutical and biotechnology firms. With a focus on collaboration and excellence, Inizio Group Limited continues to shape the future of healthcare, making a meaningful impact in the industry.
How does Inizio Group Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Inizio Group Limited's score of 71 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Inizio Group Limited, headquartered in Great Britain, reported significant carbon emissions for the year 2024, totalling approximately 38,610,000 kg CO2e. This includes 3,861,000 kg CO2e from Scope 1 emissions, 1,940,000 kg CO2e from Scope 2 (market-based), and a substantial 35,476,000 kg CO2e from Scope 3 emissions. The Scope 3 emissions breakdown reveals major contributions from purchased goods and services (17,257,000 kg CO2e), business travel (12,873,000 kg CO2e), and employee commuting (2,608,000 kg CO2e). In 2023, Inizio Group's emissions were approximately 30,210,000 kg CO2e, with Scope 1 emissions at 5,919,000 kg CO2e, Scope 2 emissions at 1,945,000 kg CO2e (location-based), and Scope 3 emissions at 30,210,000 kg CO2e. The previous year, 2022, saw total emissions of about 36,540,000 kg CO2e, with Scope 1 at 11,900,000 kg CO2e and Scope 2 at 2,315,000 kg CO2e. Inizio Group has set ambitious climate commitments, aiming for a 46.2% reduction in absolute Scope 1 and 2 GHG emissions by 2031, using 2021 as the baseline. Additionally, they target a 27.5% reduction in Scope 3 emissions from purchased goods and services, fuel- and energy-related activities, and business travel within the same timeframe. These targets are aligned with the Science Based Targets initiative (SBTi) and reflect a commitment to achieving net-zero emissions by 2050. The company acknowledges the challenges ahead in transitioning to net-zero and is actively working towards these goals, demonstrating a proactive approach to climate responsibility within the pharmaceuticals, biotechnology, and life sciences sector.
Access structured emissions data, company-specific emission factors, and source documents
2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Scope 1 | 8,008,000 | 00,000,000 | 0,000,000 | 0,000,000 |
Scope 2 | 2,846,000 | 000,000 | 000,000 | 000,000 |
Scope 3 | 18,679,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Inizio Group Limited is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.